Fig 1.
A, Total alopecia of the scalp in a patient with myeloproliferative disorder. B, Robust hair growth on the scalp after 4 months of treatment with ruxolitinib.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.